ALX ONCOLOGY HOLDINGS INC Weighted Average Number of Shares Outstanding, Basic and Diluted
ALX ONCOLOGY HOLDINGS INC (ALXO) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 40.62 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-09
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 40.62M shares, a 1.40% increase year-over-year.
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 40.53M shares, a 7.27% increase year-over-year.
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 40.40M shares, a 36.18% increase year-over-year.
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 40.25M shares, a 1171.75% increase year-over-year.
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 40.31M shares, a 118.05% increase from fiscal 2020.
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 18.49M shares, a 500.86% increase from fiscal 2019.
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 3.08M shares, a 11.84% increase from fiscal 2018.
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 2.75M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 40.62M shares 10-Q · filed 2022-05-09 | 40.57M shares derived: average of 2 quarters · filed 2022-05-09 | 40.51M shares derived: average of 3 quarters · filed 2022-05-09 | 40.45M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2021-12-31 | 40.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 40.46M shares derived: average of 2 quarters · filed 2022-02-28 | 40.39M shares derived: average of 3 quarters · filed 2022-02-28 | 40.31M shares 10-K · filed 2022-02-28 |
| 2021-09-30 | 40.40M shares 10-Q · filed 2021-11-12 | 40.32M shares derived: average of 2 quarters · filed 2021-11-12 | 40.23M shares 10-Q · filed 2021-11-12 | 39.62M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2021-06-30 | 40.25M shares 10-Q · filed 2021-08-12 | 40.15M shares 10-Q · filed 2021-08-12 | 39.36M shares derived: average of 3 quarters · filed 2022-05-09 | 36.94M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2021-03-31 | 40.06M shares 10-Q · filed 2022-05-09 | 38.92M shares derived: average of 2 quarters · filed 2022-05-09 | 35.83M shares derived: average of 3 quarters · filed 2022-05-09 | 27.67M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | 37.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 33.72M shares derived: average of 2 quarters · filed 2022-02-28 | 23.54M shares derived: average of 3 quarters · filed 2022-02-28 | 18.49M shares 10-K · filed 2022-02-28 |
| 2020-09-30 | 29.66M shares 10-Q · filed 2021-11-12 | 16.41M shares derived: average of 2 quarters · filed 2021-11-12 | 12.05M shares 10-Q · filed 2021-11-12 | 9.77M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | 3.16M shares 10-Q · filed 2021-08-12 | 3.16M shares 10-Q · filed 2021-08-12 | 3.14M shares derived: average of 3 quarters · filed 2022-02-28 | 3.13M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | 3.14M shares 10-Q · filed 2021-05-17 | 3.13M shares derived: average of 2 quarters · filed 2022-02-28 | 3.12M shares derived: average of 3 quarters · filed 2022-02-28 | 3.11M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | 3.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 3.11M shares derived: average of 2 quarters · filed 2022-02-28 | 3.10M shares derived: average of 3 quarters · filed 2022-02-28 | 3.08M shares 10-K · filed 2022-02-28 |
| 2019-09-30 | 3.10M shares 10-Q · filed 2020-11-12 | 3.09M shares derived: average of 2 quarters · filed 2020-11-12 | 3.06M shares 10-Q · filed 2020-11-12 | |
| 2019-06-30 | 3.09M shares 10-Q · filed 2020-08-27 | 3.05M shares 10-Q · filed 2020-08-27 | ||
| 2018-12-31 | 2.75M shares 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |